Evidence map›Paper›PMID 41768084›Full record

ArticleRespiratory medicine case reports2026

Autofluorescence bronchoscopy findings of pseudoprogression after neoadjuvant chemo-immunotherapy in squamous cell lung cancer: A case report.

Himeko Mori, Yasuharu Sekine, Keisuke Kuroda, Sho Ueda, Yusuke Saeki, Naohiro Kobayashi, Hideo Ichimura, Noriko Takemura-Kobayashi, Daisuke Matsubara, Yukio Sato

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Himeko MoriDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Yasuharu SekineDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Keisuke KurodaDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Sho UedaDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Yusuke SaekiDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Naohiro KobayashiDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Hideo IchimuraDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.
Noriko Takemura-KobayashiDepartment of Diagnostic Pathology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Daisuke MatsubaraDepartment of Diagnostic Pathology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yukio SatoDepartment of Thoracic Surgery, University of Tsukuba, Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, multiple clinical trials have demonstrated the efficacy of neoadjuvant chemotherapy (NAC) combined with immune checkpoint inhibitors (ICI) for stage II-III non-small cell lung cancer (NSCLC). Pseudoprogression, a phenomenon in which activated lymphocytes infiltrate tumors and cause transient enlargement, can complicate post-treatment assessment. We report a case of stage III squamous cell carcinoma in the right lower lobe with endobronchial spread treated with NAC plus ICI. Autofluorescence imaging (AFI) bronchoscopy after treatment showed further autofluorescence attenuation despite no residual malignancy, consistent with pseudoprogression. Histopathology revealed infiltration of CD4

Indexed as

Autofluorescence bronchoscopyNeoadjuvant chemo-immunotherapyNon-small cell lung cancerPseudoprogressionSquamous cell carcinoma

Identifiers

PMID41768084
PMCPMC12945578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.